Enteric immunologic abnormalities in human immunodeficiency virus infection

Seminars in Liver Disease

Volumn 12, Issue 2, 1992, Pages 167-174

  Ullrich, Reiner ^a   Zeitz, Martin ^a   Riecken, Ernst Otto ^a,b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

GASTROINTESTINAL MUCOSA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTESTINE CELL; LAMINA PROPRIA; OPPORTUNISTIC INFECTION; REVIEW; T LYMPHOCYTE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; HUMAN; INTESTINAL MUCOSA; PEYER'S PATCHES; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 0026631292     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007388     Document Type: Article

References (89)

1. Janoff EN, Smith PD: Perspectives on gastrointestinal infections in AIDS. Gastroenterol Clin North Am 17:451-63, 1988.
2. Riecken EO, Zeitz M, Ullrich R: Non-opportunistic causes of diarrhoea in HIV infection. Baillieres Clin Gastroenterol 4: 385-403, 1990.
3. Zeitz M, Schieferdecker HL, Ullrich R, et al: Phenotype and function of lamina propria T cells. Immunol Res 10:199-206, 1991.
4. McDougal JS, Kennedy MS, Sligh JM, et al: Binding of HTLV-III/LAV toT4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science 231:382-385, 1986.
5. Ho DD, Rota TR, Hirsch MS: Infection of monocyte/ macrophages by human T lymphotrophic virus type III. J Clin Invest 77:1712-15, 1986.
6. Gartner S, Markovits P, Markovitz DM, et al: The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233:215-219, 1986.
7. Stewart SJ, Fujimoto J, Levy R: Human T lymphocytes and monocytes bear the same Leu-3(T4) antigen. J Immunol 136: 3773-3738, 1986.
8. Crowe S, Mills J, McGrath MS: Quantitative immunocytofluorographic analysis of CD4 surface antigen expression and HIV infection in human peripheral blood monocyte/macrophages. AIDS Res Hum Retroviruses 3:135-145, 1987.
9. Tenner-Racz K, Racz P, Bofill M, et al: HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. Am J Pathol 123: 915, 1986.
10. Biberfeld P, Chayt KJ, Marselle LM et al: HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. Am J Pathol 125:436-442, 1986.
11. Schriever F, Freedman AS, Freeman G, et al: Isolated human follicular dendritic cells display a unique antigenic phenotype. J Exp Med 169:2043-2058, 1989.
12. Bolognesi DP: AIDS. Do antibodies enhance the infection of cells by HIV? Nature 340:431-432, 1989.
13. Rosenberg ZF, Fauci AS: Immunopathogenesis of HIV infection. FASEB J 5:2382-2390, 1991.
14. Cullen BR: Regulation of HIV-1 gene expression. FASEB J 5:2361-2368, 1991.
15. De Paoli P, Battistin S, Crovatto M, et al: Immunologic abnormalities related to antigenaemia during HIV-1 infection. Clin Exp Immunol 74:317-320, 1988.
16. Van Noesel CJ, Gruters RA, Terpstra FG, et al: Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. J Clin Invest 86:293-299, 1990.
17. Schnittman SM, Lane HC, Greenhouse J, et al: Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: Evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc Natl Acad Sci USA 87:6058-6062, 1990.
18. Pahwa S, Pahwa R, Saxinger C, et al: Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: Evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. Proc Natl Acad Sci USA 82:8198-8202, 1985.
19. Nair MP, Pottathil R, Heimer EP, Schwartz SA: Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: Effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes. Proc Natl Acad Sci USA 85:6498-6502, 1988.
20. Kornfeld H, Cruikshank WW, Pyle SW, et al: Lymphocyte activation by HIV-1 envelope glycoprotein. Nature 335:445-8, 1988.
21. Haseltine WA: Molecular biology of the human immunodeficiency virus type 1. FASEB J 5:2349-60, 1991.
22. Lane HC, Masur H, Edgar LC, et al: Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 309:453-458, 1983.
23. Lane HC, Fauci AS: Immunologic abnormalities in the acquired immunodeficiency syndrome. Annu Rev Immunol 3:477-500, 1985.
24. Shearer GM, Bernstein DC, Tung KS, et al: A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J Immunol 137:2514-21, 1986.
25. Giorgi JV, Fahey JL, Smith DC, et al: Early effects of HIV on CD4 lymphocytes in vivo. J Immunol 138:3725-3730, 1987.
26. Hoy JF, Lewis DE, Miller GG: Functional versus phenotypic analysis of T cells in subjects seropositive for the human immunodeficiency virus: A prospective study of in vitro responses to Cryptococcus neoformans. J Infect Dis 158:1071-1078, 1988.
27. Murray HW, Scavuzzo DA, Kelly CD, et al: T4+ cell production of interferon gamma and the clinical spectrum of patients at risk tor and with acquired immunodeficiency syndrome. Arch Intern Med 148:1613-1616, 1988.
28. Antonen J, Krohn K: Interleukin 2 production in HTLV-III/LAV infection: Evidence of defective antigen-induced, but normal mitogen-induced IL-2 production. Clin Exp Immunol 65:489-496, 1986.
29. Schellekens PT, Roos MT, De WF, et al: Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-1 (HIV-1)-infected men. J Clin Immunol 10:121-127, 1990.
30. Hoxie JA, Alpers JD, Rackowski JL, et al: Alterations in T4 (CD4) protein mRNA synthesis in cells infected with HIV. Science 234:1123-1127, 1986.
31. Yuille MA, Hugunin M, John P, et al: HIV-1 infection abolishes CD4 biosynthesis but not CD4 mRNA J Acquir Immune Defic Syndr 1:131-137, 1988.
32. Stevenson M, Zhang XH, Volsky DJ: Downregulation of cell surface molecules during noncytopathic infection of T cells with human immunodeficiency virus. J Virol 61:3741-3748, 1987.
33. Prince HE, Kleinman SH, Maino VC, Jackson AL: In vitro activation of T lymphocytes from human immunodeficiency virus (HIV)-seropositive blood donors. I. Soluble interleukin 2 receptor (IL2R) production parallels cellular IL2R expression and DNA synthesis. J Clin Immunol 8:114-120, 1988.
34. Popovic M, Sarngadharan MG, Read E, Gallo RC: Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS Science 224:497-500, 1984.
35. Rosenberg ZF, Fauci AS: The immunopathogenesis of HIV infection. Adv Immunol 47:377-431, 1989.
36. Amerongen HM, Weltzin R, Farnet CM, et al: Transepithelial transport of HIV-1 by intestinal M cells: A mechanism for transmission of AIDS. J Acquir Immune Defic Syndr 4:760-765, 1991.
37. James SP, Zeitz M, Kanof ME, Kwan WC: Intestinal lymphocyte populations and mechanisms of cell-mediated immunity Immunol Allergy Clin North Am 8:369-391, 1988.
38. Zeitz M, Schieferdecker HL, James SP, Riecken EO: Special functional features of T-lymphocyte subpopulations in the elfector compartment of the intestinal mucosa and their relation to mucosal transformation. Digestion 46 (Suppl 2): 280-289, 1990.
39. Mayer L, Shlien R: Evidence for function of Ia molecules on gut epithelial cells in man. J Exp Med 166:1471-1483, 1987.
40. Ullrich R, Schieferdecker HL, Jahn HU, Zeitz M: Gamma-delta T cells in the human intestine. Immunol Res 10:306-309, 1991.
41. James SP, Fiocchi C, Graeff AS, Strober W: Phenotypic analysis of lamina propria lymphocytes: Predominance of helper-inducer and cytolytic T-cell phenotypes and deficiency of suppressor-inducer phenotypes in Crohn's disease and control patients. Gastroenterology 91:1483-9, 1986.
42. James SP, Graeff AS, Zeitz M: Predominance of helper-inducer T cells in mesenteric lymph node and intestinal lamina propria lymphocytes of normal non-human primates. Cell Immunol 107:372-383, 1987.
43. Selby WS, Jannossy G, Bofill M, Jewell DP: Intestinal lymphocyte subpopulations in inflammatory bowel disease: An analysis by immunohislological and cell isolation techniques. Gut 25:32-40, 1984.
44. Schieferdecker HL, Ullrich R, Weiss-Breckwoldt AN, et al: The HML-1 antigen of intestinal lymphocytes is an activation antigen. J Immunol 144:2541-2549, 1990.
45. Zeitz M, Greene WC, Peffer NJ, James SP: Lymphocytes isolated from the intestinal lamina propria of normal nonhuman primates have increased expression of genes associated with T cell activation. Gastroenterology 94:647-655, 1988.
46. Ullrich R, Schieferdecker HL, Ziegler K, et al: γδ cells in the human intestine express surface markers of activation and are preferentially located in the epithelium. Cell Immunol 128:619-627, 1990.
47. Ullrich R, Zeitz M, Heise W, et al: Mucosal atrophy is associated with loss of activated T cells in the duodenal mucosa of human immunodeficiency virus (HIV)-infected patients. Digestion 46 (Suppl 2): 302-307, 1990.
48. Cerf-Bensussan N, Jarrv A, Brousse N, et al: A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur J Immunol 17:1279-1285, 1987.
49. Schieferdecker HL, Ullrich R, Zeitz M: Phenotype of HML-1-positive T cells in the human intestinal lamina propria. Immunol Res 10:207-210, 1991.
50. Zeitz M, Quinn TC, Graeff AS, James SP: Mucosal T cells provide helper function but do not proliferate when stimulated by specific antigen in Lymphogranuloma venereum proctitis in nonhuman primates. Gastroenterology 94:353-366, 1988.
51. Pirzer UC, Schürmann G, Post S, et al: Differential responsiveness to CD3-Ti vs CD2 dependent activation of human intestinal T lymphocytes. Eur J Immunol 20:2339-2342, 1990.
52. Qiao L, Schürmann G, Betzler M, Meuer SC: Functional properties of human lamina propria T lymphocytes assessed with mitogenic monoclonal antibodies. Immunol Res 10:218-225, 1991.
53. Nelson JA, Wiley CA, Reynolds-Kohler C, et al: Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet 1: 259-262, 1988.
54. Ullrich R, Zeitz M, Heise W, et al: Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): Evidence for HIV-induced enteropathy. Ann Intern Med 111:15-21, 1989.
55. Pox CH, Kotler D, Tierney A, et al: Detection of HIV-1 RNA in the lamina propria of patients with AIDS and gastrointestinal disease. J Infect Dis 159:467-471, 1989.
56. Jarry A, Cortez A, René E, et al: Infected cells and immune cells in the gastrointestinal tract of AIDS patients. An immunohistochemical study of 127 cases. Histopathology 16:133-140, 1990.
57. Heise C, Dandekar S, Kumar P, et al: Human immunodeficiency virus infection of enterocytes and mononuclear cells in human jejunal mucosa. Gastroenterology 100:1521-1527, 1991
58. Ullrich R, Riecken EO, Zeitz M: HIV-induced enteropathy. Immunol Res 10:456-464, 1991.
59. Racz P: Pathomorphologie des intestinalen Immunsystems. Presented at the 3rd German AIDS-Congress November 24-17, Hamburg, 1990.
60. Zeitz M, Ullrieh R, Riecken EO: The role of the gut-associated lymphoid tissue in the pathogenesis of the acquired immunodeficiency syndrome (HIV-infection). In: MacDonald TT, Challacombe SJ, Bland PW, et al (Eds): Advances in Mucosal Immunology. Proceedings of the Fifth International Congress of Mucosal Immunology. Dordrecht: Kluwer Academic Press, 1990, pp 655-659.
61. Aduchi A, Koenig S, Gendelmann HE, et al: Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J Virol 61:209-213, 1987.
62. Moyer MP, Gendelman HE: HIV replication and persistence in human gastrointestinal cells cultured in vitro. J Leukoc Biol 49:499-504, 1991.
63. Bourinbaiar AS, Phillips DM: Transmission of human immunodeficiency virus from monocytes to epithelia. J Acquir Immune Defic Syndr 4:56-63, 1991.
64. Mathijs JM, Hing M, Grierson J, et al: HIV infection of rectal mucosa. (Letter.) Lancet 1:1111, 1988.
65. Yolken RH, Hart W, Oung I, et al: Gastrointestinal dysfunction and disaccharide intolerance in children infected with human immunodeficiency virus. J Pediatr 118:359-363, 1991.
66. Rodgers VD, Fassett R, Kagnoff MF: Abnormalities in intestinal mucosal T cells in homosexual populations including those with the lymphadenopathy syndrome and acquired immunodeficiency syndrome. Gastroenterology 90:552-558, 1986.
67. Ellakany S, Whiteside TL, Schade RR, vanThiel DH: Analysis of intestinal lymphocyte subpopulations in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Am J Clin Pathol 87:356-364, 1987.
68. Budhraja M, Levendoglu H, Kocka F, et al: Duodenal mucosal T cell subpopulation and bacterial cultures in acquired immune deficiency syndrome. Am J Gastroenterol 82:427-431, 1987.
69. McDougal JS, Mawle A, Cort SP, et al: Cellular tropism of the human retrovirus HTLV-III/LAV. 1. Role of T cell activation and expression of the T4 antigen. J Immunol 135:3151-3162, 1985.
70. Mittler RS, Hoffmann MK: Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation. Science 245:1380-1382, 1989.
71. Pinching AJ. Nye KE: Defective signal transduction - a common pathway for cellular dysfunction in HIV infection? Immunol Today 11:256-259, 1990.
72. Weber JR Jr., Dobbins WO: The intestinal and rectal epithelial lymphocyte in AIDS. Am J Surg Pathol 10:627-639, 1986.
73. Batman PA, Miller ARO, Forster SM, et al: Jejunal enteropathy associated with human immunodeficiency virus infection: Quantitative histology. J Clin Pathol 42:275-281, 1989.
74. Cummins AG, LaBrooy JT, Stanley D, et al: Quantitative histological study of enteropathy associated with HIV infection. Gut 31:317-321, 1990.
75. Greenson JK, Belitsos PC, Yardley JH, Bartlett JG: AIDS enteropathy: Occult enteric infections and duodenal mucosal alterations in chronic diarrhea. Ann Intern Med 114:366-372, 1991.
76. Kotler DP, Scholes JV, Tierney AR: Intestinal plasma cell alterations in the acquired immunodeficiency syndrome. Dig Dis Sci 32:129-138, 1987.
77. Jackson S: Secretory and serum IgA are inversely altered in AIDS patients. In: MacDonald TT, Challacombe SJ, Bland PW, et al (Eds): Advances in Mucosal Immunology. Proceedings of the Fifth International Congress of Mucosal Immunology. Dordrecht, Kluwer Academic Press, 1990, pp 665-668.
78. MacDonald TT, Spencer J: Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J Exp Med 167:1341-1349, 1988.
79. Riecken EO, Stallmach A, Zeitz M, et al: Growth and transformation of the small intestinal mucosa - importance of connective tissue, gut associated lymphoid tissue and gastrointestinal regulatory peptides. Gut 30: 1630-1640, 1989.
80. Griffiths CE, Barrison IG, Leonard JN, et al: Preferential activation of CD4 T lymphocytes in the lamina propria of gluten-sensitive enteropathy. Clin Exp Immunol 72:280-283, 1988.
81. Malebranche R, Guerin JM, Laroche AC, et al: Acquired immunodeficiency syndrome with severe gastrointestinal manifestations in Haiti. Lancet 2:873-877, 1983.
82. Kotler DP, Gaetz HP, Lange M, et al: Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med 101:421-428, 1984.
83. Kotler DP, Francisco A, Clayton F, et al: Small intestinal injury and parasitic disease in AIDS. Ann Intern Med 113:444-449, 1990.
84. HIV-associated enteropathy. Lancet 2:777-8, 1989.
85. Riecken EO, Zeitz M, Ullrich R: HIV infection of the gut. In: Tsuchiya M, Nagura H, Hibi T, Moro I (Eds): Frontiers, of Mucosal Immunology, vol 1. Proceedings of the Sixth International Congress of Mucosal Immunology, Tokyo 1990 Amsterdam, Excerpta Medica, 1991, pp 619-622.
86. Ullrich R, Heise W, Bergs C, et al: Effects of zidovudine treatment on the small intestinal mucosa in patients infected with HIV. Gastroenterology 1992 (in press).
87. + (T cell receptor α/β or γ/δ) and CD3-lymphocytes isolated from normal human gut epithelium display phenotypical features different from their counterparts in peripheral blood. Eur J Immunol 20:1097-1103, 1990.
88. Centers for Disease Control: Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR 35:334-339, 1986.
89. Leads from the MMWR (Morbidity and Mortality Weekly Report). Supplement 15. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. JAMA 258:1143-1154, 1987.